Bay Colony Advisory Group, Inc D Astrazeneca PLC Transaction History
Bay Colony Advisory Group, Inc D
- $786 Million
- Q3 2025
A detailed history of Bay Colony Advisory Group, Inc D transactions in Astrazeneca PLC stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 25,596 shares of AZN stock, worth $2.29 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
25,596
Previous 22,834
12.1%
Holding current value
$2.29 Million
Previous $1.6 Million
23.07%
% of portfolio
0.25%
Previous 0.23%
Shares
15 transactions
Others Institutions Holding AZN
# of Institutions
1,541Shares Held
503MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...